Lv1
50 积分 2023-01-08 加入
doi: 10.1016/S1470-2045(24)00581-3. Epub 2024 Nov 26. De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
16小时前
已完结
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
1天前
已完结
皖公网安备34019202002308
